Market Place
Sourcing Support
Pfizer Delays Patent Cliff For Blockbuster Vyndamax
28 Apr 2026 //
ENDPOINTS
Pfizer Secures Deals to Block Heart Drug Generics Until 2030
28 Apr 2026 //
REUTERS
Pfizer, Teva lose bid to disqualify ex-prosecutor in generic drug
12 Mar 2026 //
REUTERS
China Approves Pfizer GLP-1 Drug for Weight Loss
06 Mar 2026 //
REUTERS
Bridgebio Shares Slide On Pfizer`s ATTR Patent Withdrawal
06 Feb 2026 //
FIERCE PHARMA
NastLaw Announces Settlement in Generic Pharma Pricing Litigation
11 Sep 2025 //
PR NEWSWIRE
Pfizer Completes Licensing Agreement with 3SBio
26 Jul 2025 //
PRESS RELEASE
Delaware Court Backs Zantac Drugmakers in Cancer Lawsuits
12 Jul 2025 //
REUTERS
Singleton Schreiber Leads Effort for Women Affected by Depo-Provera
01 Apr 2025 //
ACCESSWIRE
First trial over Zantac cancer claims set to begin in Chicago
01 May 2024 //
REUTERS
Pfizer to pay $25.5 mln to settle remaining Effexor XR antitrust claims
30 Apr 2024 //
REUTERS
Study finds generic drugs gain, but docs still prefer brands; Pfizer at AACR
09 Apr 2024 //
ENDPTS
Endo sues Zydus to block generic version of Pfizer`s Chantix
11 Aug 2023 //
REUTERS
Viatris leans in on brand drug portfolio for future growth
08 May 2023 //
ENDPTS
Pfizer CEO rules out generic COVID drug Paxlovid for China
10 Jan 2023 //
REUTERS
Appeals court sides with Pfizer in patent fight with Astellas
05 Jan 2023 //
FIERCE PHARMA
Pfizer CEO reveals 2030 growth plan as company faces up to $18 billion revenue
01 Nov 2022 //
CNBC
Pfizer to allow generic COVID pill in 95 countries
17 Nov 2021 //
EXPRESSPHARMA
Pfizer deal allows generic versions of COVID pill for low-income countries
17 Nov 2021 //
PHARMAFILE
Pfizer strikes deal to allow generic versions of its Covid pill for world’s poor
16 Nov 2021 //
THEGUARDIAN
Pfizer to allow generic versions of its COVID-19 pill in 95 countries
16 Nov 2021 //
ECONOMICTIMES
Pfizer to allow generic versions of its Covid pill for poor countries
16 Nov 2021 //
FRANCE24
Attorneys general bring another ‘collusion’ case against generic makers
12 Jun 2020 //
ENDPTS
States file 3rd generics price-fixing suit against 26 firms
11 Jun 2020 //
FIERCEPHARMA
Pressure on generic drugmakers increases with new price fixing lawsuit
10 Jun 2020 //
BIOPHARMADIVE
Pfizer, Ranbaxy Sued Over Delay Of Generic Lipitor
26 May 2020 //
LAW360
Mylan offers concessions to address EU concerns about Pfizer deal
01 Apr 2020 //
REUTERS
EpiPen Buyers Tear Into Mylan, Pfizer Bid For Cert. Review
25 Mar 2020 //
LAW360
Pfizer Sues to Block Copies of Smoking-Cessation Pill Chantix
04 Feb 2020 //
BLOOMBERGLAW
Pfizer, Astellas` Xtandi matches J&J`s Erleada with new FDA nod
17 Dec 2019 //
FIERCE PHARMA
Say hello to Viatris: Pfizer`s Upjohn, Mylan merger gets a name
13 Nov 2019 //
FIERCE PHARMA
UPDATE 3-Mylan shares slide after warning of hit to revenue
06 Nov 2019 //
CNBC
Think Mylan`s done with M&A after its Pfizer deal? Think again
05 Nov 2019 //
FIERCE PHARMA
J&J finds competitive edge with latest Erleada approval
19 Sep 2019 //
BIOPHARMADIVE
U.S. FDA approves Mylan generic of Lilly lung cancer drug Alimta
03 Sep 2019 //
CNBC
Pfizer`s Lyrica market share crumbles under generic onslaught
20 Aug 2019 //
FIERCE PHARMA
The top 10 all-time biggest-selling drugs by 2024
15 Aug 2019 //
FIERCE PHARMA
GSK completes transaction with Pfizer
02 Aug 2019 //
PRESS RELEASE
With its generic spin-off cash, will Pfizer step up its buying game?
31 Jul 2019 //
FIERCE PHARMA
FDA approves nine generic versions of Pfizer`s Lyrica
25 Jul 2019 //
PHARMAFILE
Pfizer To Launch Several Drugs Despite Generic Headwinds
05 Jun 2019 //
BIOSIMILAR DEVELOPMENT
AstraZeneca`s Faslodex gets U.S. generic on heels of record sales year
31 May 2019 //
FIERCE PHARMA
Generics `cartel` reaped billions from price fixing: lawsuit
14 May 2019 //
FIERCE PHARMA
Celltrion gets FDA approval for antibiotic generic
09 May 2019 //
IN-PHARMATECHNOLOGIST
Hundreds of EpiPen users complained about problems with the lifesaving device
01 Feb 2019 //
BUSINESS INSIDER
Teva`s generic EpiPen launch stalls months after approval
31 Jan 2019 //
REUTERS
Xeljanz XR® (tofacitinib ER tablets) : Pfizer v. Teva Pharmaceuticals
13 Dec 2018 //
PATENT LITIGATION
Xeljanz XR (tofacitinib) : Pfizer vs. Teva Pharmaceutical
10 Dec 2018 //
PATENT LITIGATION
J&J unit to pay $360 million to U.S. to resolve charity kickback probe
07 Dec 2018 //
REUTERS
Imbruvica (ibrutinib): Pharmacyclics, Janssen Biotech vs. Hetero Labs
24 Nov 2018 //
PATENT LITIGATION
U.S. appeals court declines J&J bid to stop generic Zytiga sales
22 Nov 2018 //
REUTERS
Pfizer loses drug patent fight in UK top court, may face claims
15 Nov 2018 //
REUTERS
Pfizer and Mylan Report EpiPen Label Defect Could Delay, Prevent Emergency Use
05 Nov 2018 //
RAPS
Mylan and Pfizer report new issues affecting some EpiPens
03 Nov 2018 //
FIERCE PHARMA
Lexiscan (regadenoson) : Astellas Pharma, Gilead Sciences vs. Apotex
01 Nov 2018 //
PATENT LITIGATION
Mylan secretly maneuvered to suppress evidence in EpiPen suit, plaintiffs say
04 Oct 2018 //
FIERCE PHARMA
Xeljanz XR (tofacitinib): Pfizer vs. Sun Pharmaceutical
03 Oct 2018 //
PATENT LITIGATION
Drugmakers Call for Changes, Additions to FDA’s Purple Book
27 Sep 2018 //
RAPS
EpiPen partners Mylan, Pfizer have to fight class action antitrust claims
22 Aug 2018 //
FIERCE PHARMA
